Scholarlink

Background <p>This study was aimed to evaluate the renoprotective effects of Myricetin at two dosages (50 and 100&#xa0;mg/kg) within an experimental I/R injury model. The analysis focused on key immunological and oxidative stress pathways, including the regulation of pro- and anti-inflammatory cytokines, NF-κB and TLR4 signaling, as well as biomarkers of oxidative stress such as nitrate (NO), malondialdehyde (MDA), glutathione (GSH), nuclear factor (erythroid-derived 2)-like 2 (NRF2) and Heme oxygenase-1 (HO-1).</p> Methods and results <p>Thirty female Wistar albino rats were randomly assigned to six groups. Myricetin was administered via intragastric gavage for seven days before ischemia/reperfusion. Renal ischemia was induced by clamping the left renal pedicle for 45&#xa0;min, followed by a 3-hour reperfusion period. Kidney tissues were collected for histopathological, immunohistochemical, and biochemical analyses. Serum cytokine levels were measured by ELISA, while protein expressions were evaluated by Western blotting. I/R injury significantly increased pro-inflammatory cytokines and oxidative stress markers, alongside heightened NF-κB immunopositivity and TNF-α, IL-1β expression. Myricetin administration reduced pro-inflammatory cytokines, increased anti-inflammatory cytokines, and enhanced antioxidant responses. Immunohistochemical and Western blot analyses showed decreased NF-κB positivity and increased NRF2 expression.</p> Conclusions <p>The renoprotective effects of Myricetin appear to be mediated by inhibiting the NF-κB pathway, reducing inflammation, and enhancing antioxidant responses. Furthermore, Myricetin activates the NRF2/HO-1 pathway, suggesting its potential as a therapeutic agent for ischemia/reperfusion-induced kidney injury.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The beneficial effects of dose-dependent myricetin application on renal ischemia and reperfusion injury in a rat model

  • 期刊论文

  • 发表日期：

    2025年9月16日

查看全文
  • Mert Sezer,
  • Yusuf Umut Bati,
  • Nazli Yerli,
  • Soner Kina,
  • Lale Baser,
  • Selina Aksak Karamese

摘要

Background

This study was aimed to evaluate the renoprotective effects of Myricetin at two dosages (50 and 100 mg/kg) within an experimental I/R injury model. The analysis focused on key immunological and oxidative stress pathways, including the regulation of pro- and anti-inflammatory cytokines, NF-κB and TLR4 signaling, as well as biomarkers of oxidative stress such as nitrate (NO), malondialdehyde (MDA), glutathione (GSH), nuclear factor (erythroid-derived 2)-like 2 (NRF2) and Heme oxygenase-1 (HO-1).

Methods and results

Thirty female Wistar albino rats were randomly assigned to six groups. Myricetin was administered via intragastric gavage for seven days before ischemia/reperfusion. Renal ischemia was induced by clamping the left renal pedicle for 45 min, followed by a 3-hour reperfusion period. Kidney tissues were collected for histopathological, immunohistochemical, and biochemical analyses. Serum cytokine levels were measured by ELISA, while protein expressions were evaluated by Western blotting. I/R injury significantly increased pro-inflammatory cytokines and oxidative stress markers, alongside heightened NF-κB immunopositivity and TNF-α, IL-1β expression. Myricetin administration reduced pro-inflammatory cytokines, increased anti-inflammatory cytokines, and enhanced antioxidant responses. Immunohistochemical and Western blot analyses showed decreased NF-κB positivity and increased NRF2 expression.

Conclusions

The renoprotective effects of Myricetin appear to be mediated by inhibiting the NF-κB pathway, reducing inflammation, and enhancing antioxidant responses. Furthermore, Myricetin activates the NRF2/HO-1 pathway, suggesting its potential as a therapeutic agent for ischemia/reperfusion-induced kidney injury.